Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 randomized conversion study of basal insulin/metformin with lobeglitazone or linagliptin in type 2 diabetes
KCT0002852Phase 4Recruiting
- Sponsor
- Chong Kun Dang
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lobeglitazone, linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Chong Kun Dang. Started Feb 2018; status: recruiting.
02
Drugs
lobeglitazonelinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0002852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002852.